Abstract
Formulations designed to be applied to the skin, in particular for the treatment of skin diseases are commonly used for children. There are a number of important issues with regards to the use of these types medicines in the pediatric population in comparison to adults; for example children have a greater risk of experiencing systemic side effects as a result of treatment. This chapter discusses the roles of the different formulations used for topical and transdermal treatment, their design and considerations specifically relevant for the development of these medicines for children.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bechelli LM, Haddad N, Pimenta WP, Pagnano PMG, Melchior E, Fregnan RC, Zanin LC, Arenas A (1981) Epidemiological survey of skin diseases in school-children living in the Purus valley (Acre state, Amazonia, Brazil). Dermatologica 163(1):78–93
Dogra S, Kumar B (2003) Epidemiology of skin diseases in school children: a study from northern India. Pediatr Dermatol 20(6):470–473
Fergusson DM, Dimond ME, Shannon FT (1984) Morbidity during the preschool years. Aust Paediatr J 20(4):281–287
Kottenhahn RK, Heck JE (1994) Prevalence of pediatric skin diseases in rural Honduras. Trop Doct 24(2):87–88
Mahe A, Prual A, Konate M, Bobin P (1995) Skin diseases of children in Mali – a public-health problem. Trans R Soc Trop Med Hyg 89(5):467–470
Popescu R, Popescu CM, Williams HC, Forsea D (1999) The prevalence of skin conditions in Romanian school children. Br J Dermatol 140(5):891–896
Ghodsi SZ, Orawa H, Zouboulis CC (2009) Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study. J Invest Dermatol 129(9):2136–2141
Foley P, Zuo YQ, Plunkett A, Marks R (2001) The frequency of common skin conditions in preschool-age children in Australia – atopic dermatitis. Arch Dermatol 137(3):293–300
Mar A, Marks R (1999) The descriptive epidemiology of atopic dermatitis in the community. Australas J Dermatol 40(2):73–78
Peat JK, Vandenberg RH, Green WF, Mellis CM, Leeder SR, Woolcock AJ (1994) Changing prevalence of asthma in Australian children. Br Med J 308(6944):1591–1596
Schultz Larsen F (1993) The epidemiology of atopic dermatitis. In: Burr ML (ed) Epidemiology of clinical allergy. Monographs in allergy. S. Karger AG, Basel, 9–28
Walker RB, Warin RP (1956) The incidence of eczema in early childhood. Br J Dermatol 68(5):182–183
Williams HC (1992) Is the prevalence of atopic-dermatitis increasing. Clin Exp Dermatol 17(6):385–391
Kay J, Gawkrodger DJ, Mortimer MJ, Jaron AG (1994) The prevalence of childhood atopic eczema in a general-population. J Am Acad Dermatol 30(1):35–39
Correale CE, Walker C, Murphy L, Craig TJ (1999) Atopic dermatitis: a review of diagnosis and treatment. Am Fam Physician 60(4):1191–1198
Ozkaya E (2005) Adult-onset atopic dermatitis. J Am Acad Dermatol 52(4):579–582
Williams HC, Strachan DP (1998) The natural history of childhood eczema: observations from the British 1958 birth cohort study. Br J Dermatol 139(5):834–839
Lello J, Pearl A, Arroll B, Yallop J, Birchall NM (1995) Prevalence of acne-vulgaris in Auckland senior high-school-students. N Z Med J 108(1004):287–289
Lucky AW, Biro FM, Huster GA, Morrison JA, Elder N (1991) Acne-vulgaris in early adolescent boys – correlations with pubertal maturation and age. Arch Dermatol 127(2):210–216
Rademaker M, Garioch JJ, Simpson NB (1989) Acne in schoolchildren no longer a concern for dermatologists. Br Med J 298(6682):1218–1219
Goulden V, Stables GI, Cunliffe WJ (1999) Prevalence of facial acne in adults. J Am Acad Dermatol 41(4):577–580
Jordan WE, Lawson KD, Berg RW, Franxman JJ, Marrer AM (1986) Diaper dermatitis: frequency and severity among a general infant population. Pediatr Dermatol 3(3):198–207
Philipp R, Hughes A, Golding J (1997) Getting to the bottom of nappy rash. Br J Gen Pract 47(421):493–497
Virgili A, Corazza M, Califano A (1998) Diaper dermatitis in an adult – a case of erythema papuloerosive of Sevestre and Jacquet. J Reprod Med 43(11):949–951
Fantl J, Newman D, Colling J et al (1996) Urinary incontinence in adults: acute and chronic management: clinical practice guideline number 2, 1996 update (Report No. 96-0682). Agency for Health Care Policy and Research (AHCPR), Rockville
Ward DB, Fleischer AB, Feldman SR, Krowchuk DP (2000) Characterization of diaper dermatitis in the United States. Arch Pediatr Adolesc Med 154(9):943–946
Fan X, Xiao FL, Yang S, Liu JB, Yan KL, Liang YH, Sun LD, Du WH, Jin YT, Zhang XJ (2007) Childhood psoriasis: a study of 277 patients from China. J Eur Acad Dermatol Venereol 21(6):762–765
Kumar B, Jain R, Sandhu K, Kaur I, Handa S (2004) Epidemiology of childhood psoriasis: a study of 419 patients from northern India. Int J Dermatol 43(9):654–658
Nanda A, Kaur S, Kaur I, Kumar B (1990) Childhood psoriasis – an epidemiologic survey of 112 patients. Pediatr Dermatol 7(1):19–21
Seyhan M, Coskun BK, Saglam H, Ozcan H, Karincaoglu Y (2006) Psoriasis in childhood and adolescence: evaluation of demographic and clinical features. Pediatr Int 48(6):525–530
Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis D (2005) Prevalence and treatment of psoriasis in the United Kingdom – a population-based study. Arch Dermatol 141(12):1537–1541
Augustin M, Glaeske G, Radtke MA, Christophers E, Reich K, Schaefer I (2010) Epidemiology and comorbidity of psoriasis in children. Br J Dermatol 162(3):633–636
Barisic-Drusko V, Paljan D, Kansky A, Vujasinovic S (1989) Prevalence of psoriasis in Croatia. Acta Derm Venereol Suppl 146:178–179
Braathen LR, Botten G, Bjerkedal T (1989) Psoriatics in Norway – a questionnaire study on health-status, contact with paramedical professions, and alcohol and tobacco consumption. Acta Derm Venereol Suppl (Stockh) 142:9–12
Brandrup F, Green A (1981) The prevalence of psoriasis in Denmark. Acta Derm Venereol 61(4):344–346
Falk ES, Vandbakk O (1993) Prevalence of psoriasis in a Norwegian Lapp population. Acta Derm Venereol Suppl (Stockh) 182:6–9
Gelfand JM, Stern RS, Nijsten T, Feldman SR, Thomas J, Kist J, Rolstad T, Margolis DJ (2005) The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol 52(1):23–26
Kavli G, Forde OH, Arnesen E, Stenvold SE (1985) Psoriasis – familial predisposition and environmental-factors. Br Med J 291(6501):999–1000
Kavli G, Stenvold SE, Vandbakk O (1985) Low prevalence of psoriasis in Norwegian Lapps. Acta Derm Venereol 65(3):262–263
Koo J (1996) Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin 14(3):485–496
Lindegard B (1986) Diseases associated with psoriasis in a general-population of 159,200 middle-aged, urban, native Swedes. Dermatologica 172(6):298–304
Lomholt G (1964) Prevalence of skin diseases in a population; a census study from the Faroe Islands. Dan Med Bull 11:1–7
Naldi L, Colombo P, Placchesi EB, Piccitto R, Chatenoud L, La Vecchia C (2004) Study design and preliminary results from the pilot phase of the PraKtis study: self-reported diagnoses of selected skin diseases in a representative sample of the Italian population. Dermatology 208(1):38–42
Nevitt GJ, Hutchinson PE (1996) Psoriasis in the community: prevalence, severity and patients’ beliefs and attitudes towards the disease. Br J Dermatol 135(4):533–537
Quirk CJ (1979) Skin-disease in the Busselton population survey. Med J Aust 1(12):569–570
Rea JN, Newhouse ML, Halil T (1976) Skin-disease in Lambeth – community study of prevalence and use of medical-care. Br J Prev Soc Med 30(2):107–114
Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T (2004) Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 9(2):136–139
Yip SY (1984) The prevalence of psoriasis in the mongoloid race. J Am Acad Dermatol 10(6):965–968
Williams H (1998) Epidemiology of skin diseases. In: Champion R, Burton J, Burns D, Breathnach S (eds) Textbook of dermatology. Blackwell Science, Oxford, pp 139–158
Beasley R, Keil U, von Mutius E, Pearce N, Ait-Khaled N, Anabwani G, Anderson HR, Asher MI, Bjorkstein B, Burr ML, Clayton TO, Crane J, Ellwood P, Lai CKW, Mallol J, Martinez FD, Mitchell EA, Montefort S, Robertson CF, Shah JR, Sibbald B, Stewart AW, Strachan DP, Weiland SK, Williams HC (1998) Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: Isaac. Lancet 351(9111):1225–1232
Laughter D, Istvan JA, Tofte SJ, Hanifin JM (2000) The prevalence of atopic dermatitis in Oregon schoolchildren. J Am Acad Dermatol 43(4):649–655
Wiedersberg S, Naik A, Leopold CS, Guy RH (2009) Pharmacodynamics and dermatopharmacokinetics of betamethasone 17-valerate: assessment of topical bioavailability. Br J Dermatol 160(3):676–686
Brown MB, Traynor MJ, Martin GP, Akomeah FK (2008) Transdermal drug delivery systems: skin perturbation devices. In: Jain K (ed) Methods in molecular biology. Humana Press, New Jersey
O’Regan GM, Sandilands A, McLean WHI, Irvine AD (2009) Filaggrin in atopic dermatitis. J Allergy Clin Immunol 124(3):R2–R6
Janssens M, van Smeden J, Gooris GS, Bras W, Portale G, Caspers PJ, Vreeken RJ, Hankemeier T, Kezic S, Wolterbeek R, Lavrijsen AP, Bouwstra JA (2012) Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients. J Lipid Res 53(12):2755–2766
Hardman M, Byrne C (2006) Skin structural development. In: Elias P, Feingold K (eds) Skin barrier. Taylor & Francis, New York
Kalia YN, Nonato LB, Lund CH, Guy RH (1998) Development of skin barrier function in premature infants. J Invest Dermatol 111(2):320–326
Cartwright RG, Cartlidge PHT, Rutter N, Melia CD, Davis SS (1990) Transdermal delivery of theophylline to premature-infants using a hydrogel disk system. Br J Clin Pharmacol 29(5):533–539
Coureau B, Bussieres J-F, Tremblay S (2008) Cushing’s syndrome induced by misuse of moderate- to high-potency topical corticosteroids. Ann Pharmacother 42(12):1903–1907
Singal A, Thami GP (2006) Lindane neurotoxicity in childhood. Am J Ther 13(3):277–280
Zhai HB, Meier-Davis SR, Cayme B, Shudo J, Maibach H (2012) Irritant contact dermatitis: effect of age. Cutan Ocul Toxicol 31(2):138–143
Wester R, Maibach H (2005) Regional variation in percutaneous absorption: principles and applications to human risk assessment. In: Bronaugh RL, Maibach HI (eds) Percutaneous absorption drugs – cosmetics – mechanisms – methodology, 4th edn. Taylor & Francis Group, Boca Raton, pp 85–93
Ogiso T, Shiraki T, Okajima K, Tanino T, Iwaki M, Wada T (2002) Transfollicular drug delivery: penetration of drugs through human scalp skin and comparison of penetration between scalp and abdominal skins in vitro. J Drug Target 10(5):369–378
Ortiz PG, Hansen SH, Shah VP, Menne T, Benfeldt E (2009) Impact of adult atopic dermatitis on topical drug penetration: assessment by cutaneous microdialysis and tape stripping. Acta Derm Venereol 89(1):33–38
Ozon A, Cetinkaya S, Alikasifoglu A, Gonc EN, Sen Y, Kandemir N (2007) Inappropriate use of potent topical glucocorticoids in infants. J Pediatr Endocrinol Metab 20(2):219–225
Gould AR, Sharp PJ, Smith DR, Stegink AJ, Chase CJ, Kovacs JC, Penglis S, Chatterton BE, Bunn CL (2003) Increased permeability of psoriatic skin to the protein, plasminogen activator inhibitor 2. Arch Dermatol Res 295(6):249–254
Singh P, Roberts MS (1994) Skin permeability and local tissue concentrations of nonsteroidal antiinflammatory drugs after topical application. J Pharmacol Exp Ther 268(1):144–151
Magnusson BM, Pugh WJ, Roberts MS (2004) Simple rules defining the potential of compounds for transdermal delivery or toxicity. Pharm Res 21(6):1047–1054
Reid ML, Jones SA, Brown MB (2009) Transient drug supersaturation kinetics of beclomethasone dipropionate in rapidly drying films. Int J Pharm 371(1–2):114–119
Stoughton RB, Wullich K (1989) The same glucocorticoid in brand-name products – does increasing the concentration result in greater topical biologic activity. Arch Dermatol 125(11):1509–1511
British National Formulary 65 (2013) British Medical Association and the Royal Pharmaceutical Society of Great Britain, London
Trottet L, Owen H, Holme P, Heylings J, Collin IP, Breen AP, Siyad MN, Nandra RS, Davis AF (2005) Are all aciclovir cream formulations bioequivalent? Int J Pharm 304(1–2):63–71
Alberti I, Kalia YN, Naik A, Bonny JD, Guy RH (2001) Effect of ethanol and isopropyl myristate on the availability of topical terbinafine in human stratum corneum, in vivo. Int J Pharm 219(1–2):11–19
Williams AC, Barry BW (2004) Penetration enhancers. Adv Drug Deliv Rev 56(5):603–618
Lee PJ, Ahmad N, Langer R, Mitragotri S, Shastri VP (2006) Evaluation of chemical enhancers in the transdermal delivery of lidocaine. Int J Pharm 308(1–2):33–39
Sato K, Sugibayashi K, Morimoto Y (1988) Effect and mode of action of aliphatic esters on the in vitro skin permeation of nicorandil. Int J Pharm 43(1–2):31–40
Hollingsbee DA, Fairbrother JE, Martin GP, Marriott C, Monger L (1991) The effect of a hydrocolloid dermatological patch (actiderm) in potentiating the skin blanching activity of triamcinolone acetonide. Int J Pharm 77(2–3):199–209
Pershing LK, Silver BS, Krueger GG, Shah VP, Skelley JP (1992) Feasibility of measuring the bioavailability of topical betamethasone dipropionate in commercial formulations using drug content in skin and a skin blanching bioassay. Pharm Res 9(1):45–51
Curdy C, Naik A, Kalia YN, Alberti I, Guy RH (2004) Non-invasive assessment of the effect of formulation excipients on stratum corneum barrier function in vivo. Int J Pharm 271(1–2):251–256
National Psoriasis Foundation (2009) Topical treatments for psoriasis, including steroids. http://www.psoriasis.org/document.doc?id=164
Gupta G, Mallefet P, Kress DW, Sergeant A (2009) Adherence to topical dermatological therapy: lessons from oral drug treatment. Br J Dermatol 161(2):221–227
Ellis RM, Koch LH, McGuire E, Williams JV (2011) Potential barriers to adherence in pediatric dermatology. Pediatr Dermatol 28(3):242–244
Arzhavitina A, Steckel H (2010) Foams for pharmaceutical and cosmetic application. Int J Pharm 394(1–2):1–17
Andreassi L, Giannetti A, Milani M (2003) Efficacy of betamethasone valerate mousse in comparison with standard therapies on scalp psoriasis: an open, multicentre, randomized, controlled, cross-over study on 241 patients. Br J Dermatol 148(1):134–138
Lloyd A, Hodgkins P, Dewilde S, Sasane R, Falconer S, Barke ES (2011) Methylphenidate delivery mechanisms for the treatment of children with attention deficit hyperactivity disorder: heterogeneity in parent preferences. Int J Technol Assess Health Care 27(3):215–223
Zernikow B, Michel E, Anderson B (2007) Transdermal fentanyl in childhood and adolescence: a comprehensive literature review. J Pain 8(3):187–207
Teske J, Weller J-P, Larsch K, Troeger HD, Karst M (2007) Fatal outcome in a child after ingestion of a transdermal fentanyl patch. Int J Leg Med 121(2):147–151
Wokovich AM, Shen M, Doub WH, Machado SG, Buhse LF (2011) Evaluating elevated release liner adhesion of a transdermal drug delivery system (TDDS): a study of Daytrana methylphenidate transdermal system. Drug Dev Ind Pharm 37(10):1217–1224
Effendy I, Maibach HI (1996) Detergent and skin irritation. Clin Dermatol 14(1):15–21
Cork M, Timmins J, Holden C, Carr J, Berry V, Tazi-Ahnini R, Ward S (2003) An audit of adverse drug reactions to aqueous cream in children with atopic eczema. Pharm J 271:747–748
Tsang M, Guy RH (2010) Effect of aqueous cream BP on human stratum corneum in vivo. Br J Dermatol 163(5):954–958
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 American Association of Pharmaceutical Scientists
About this chapter
Cite this chapter
McAuley, W.J., Traynor, M., Brown, M.B. (2014). Topical and Transdermal. In: Bar-Shalom, D., Rose, K. (eds) Pediatric Formulations. AAPS Advances in the Pharmaceutical Sciences Series, vol 11. Springer, New York, NY. https://doi.org/10.1007/978-1-4899-8011-3_16
Download citation
DOI: https://doi.org/10.1007/978-1-4899-8011-3_16
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4899-8010-6
Online ISBN: 978-1-4899-8011-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)